Related Experiment Videos

Insulin and steatonecrosis: are they related?

J M Amatruda¹, A I Salhanick

¹University of Rochester School of Medicine, New York 14642.

Hepatology (Baltimore, Md.)

|December 1, 1989

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and pioglitazone on glycemic control and measures of β-cell function in patients with type 2 diabetes.

International journal of clinical practice·2011

Efficacy and safety of sitagliptin monotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial.

Diabetes, obesity & metabolism·2010

A one-year study to assess the safety and efficacy of the CB1R inverse agonist taranabant in overweight and obese patients with type 2 diabetes.

Diabetes, obesity & metabolism·2010

Safety and efficacy of treatment with sitagliptin or glipizide in patients with type 2 diabetes inadequately controlled on metformin: a 2-year study.

International journal of clinical practice·2010

Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes.

Diabetes, obesity & metabolism·2010

A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study.

International journal of obesity (2005)·2010

See all related articles